Skip to main content
. 2023 Nov 20;24(22):16544. doi: 10.3390/ijms242216544

Figure 2.

Figure 2

Summary of the main outcomes observed with the administration of secretome or its vesicular fraction for the treatment of neurologic disorders. The arrows indicate an increase (↑) or decrease (↓) in the respective processes or molecules.